Detection and quantitation of β-blockers in plasma and urine
Pranav S Shrivastav1, Shailesh M Buha, Mallika Sanyal
1Chemistry Department, School of Sciences, Gujarat University, Navrangpura, Ahmedabad-380009. pranav_shrivastav@yahoo.com
Abstract:
β-blockers are a class of antihypertensive drugs that are used for the management of cardiac arrhythmias, cardioprotection after myocardial infarction (heart attack) and hypertension. They have revolutionized the medical management of angina pectoris and are recommended as first-line agents by national and international guidelines. Although β-blockers are still the cornerstone for the treatment of heart failure, some of the drugs in this category are prohibited in several sports requiring vehicle control and bodily movements as they reduce heart rate and tremors, and improve performance. As a result, urine analysis of β-blockers is mandatory in doping control and toxicological screening. The determination of plasma levels of β-blockers helps to ensure noncompliance in patients with persistent hypertonia to confirm the diagnosis of β-blocker poisoning and for therapeutic drug monitoring. This review provides a comprehensive account of various analytical methods developed for detection and quantitation of β-blockers in plasma and urine.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
Measurement of Bioavailability: Pharmacokinetic Methods
Drug Concentrations: Measurements
Plasma —...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Antihypertensive Drugs: Types of β-Blockers
Therapeutic Drug Monitoring: Drug Analysis Methods


